Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
Authors:
Open Access
- 17 March 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (11) , e33279
Abstract
The neutrophil-to-lymphocyte ratio (NLR) is a prognostic inflammatory marker in colorectal cancer (CRC), however, little is known for its prognostic role in stage II to III CRC patients underwent curative resection. This study was aimed to investigate prognostic role of NLR in stage II to III CRC patients underwent surgery. Medical records of 1378 newly diagnosed CRC patients between June 2006 and March 2020 were reviewed. Data were collected by using electronic medical record software. Survival rate were analyzed using the Kaplan–Meier method. The cutoff values of NLR in stage II to III CRC patients were defined by maximally selected log-rank statistics. Multivariable cox proportional-hazard models were performed to find risk factors associated with overall survival (OS) in stage II to III CRC patients underwent surgery. Among 1378 CRC patients enrolled, 910 patients underwent surgery. In entire surgical cohort, age, body mass index (BMI), CEA, carbohydrate antigen 19-9 (CA 19-9), lymphatic invasion, NLR, and albumin-to-globulin ratio (AGR) were found to be risk factors associated with OS (all P < .05). In stage II to III CRC patients underwent curative resection (n = 623), age, BMI, lymphatic invasion, AGR, and NLR were found to be risk factors associated with OS (all P < .05). In the multivariable analysis, CA 19-9 and lymphatic invasion were independent risk factors for OS in entire surgical cohort. In the multivariable analysis for the stage II to III CRC patients, age, BMI, lymphatic invasion and NLR (Hazard ratio = 2.41, 95% confidential interval [CI]: 1.04–5.595, P = .041) were independent risk factors for OS. NLR can be used as a clinically simple and useful parameter for predicting OS in stage II to III CRC patients undergoing curative resection, however, its optimal cutoff value should be further evaluated.Keywords
This publication has 26 references indexed in Scilit:
- Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal CancerAnnals of Surgical Oncology, 2015
- Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1‐2N0 colorectal cancerJournal of Surgical Oncology, 2015
- Specific metabolic biomarkers as risk and prognostic factors in colorectal cancerWorld Journal of Gastroenterology, 2014
- Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysisInternational Journal of Cancer, 2013
- AJCC Cancer Staging Manual 7th Edition Criteria for Colon Cancer: Do the Complex Modifications Improve Prognostic Assessment?Journal of the American College of Surgeons, 2013
- The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancerInternational Journal of Colorectal Disease, 2013
- Prognostic and survival analysis of 837 Chinese colorectal cancer patientsWorld Journal of Gastroenterology, 2013
- Preoperative Carbohydrate Antigen 19-9 Levels Can Predict Stage and Survival Rate in Patients with Colorectal CancerIntestinal Research, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI: Journal of the National Cancer Institute, 2004